In 2024, the Tecan share declined by 41.0%, reflecting both the need to adjust initial business expectations during the year and the broader challenges faced by the Life Science Tools sector. This sector underperformed the market for the third consecutive year, impacted by extended bioprocessing destocking timelines, a challenging funding environment for biotech companies, tighter pharmaceutical budgets, and macroeconomic pressures in China.
The SPI Extra, Tecan's main benchmark, achieved a gain of 3.8%, while the SMI, covering Swiss blue-chip stocks, rose by 3.5%. In contrast, the US market demonstrated strong performance, with the MSCI World Index increasing by 29% in Swiss francs, driven significantly by the "Magnificent Seven" technology stocks.
The Life Science Tools sector, which Tecan is considered part of, has underperformed the broader market for the second year in a row. Healthcare stocks were generally under-owned as was the Life Science Tools sector specifically within healthcare following robust COVID over-performance in 2020 and 2021. The underperformance of the sector in 2023 was driven by a myriad of headwinds including: the elongation of bioprocessing destocking timelines, a difficult funding environment for biotech companies, tighter pharma budgets and a deteriorating macro environment in China that reverberated across the entire sector.
At CHF 343.40, shares of Tecan finished the year at -16.7% and a market capitalization of CHF 4.4 billion at the end of the year.
SHARE INFORMATION
Listing: | SIX Swiss Exchange |
Stock name: | Tecan Group |
Security number: | 1210019 |
ISIN: | CH0012100191 |
Bloomberg: | TECN SW |
Reuters: | TECN.S |
TECAN SHARE
| 2022 | 2023 | 2024 |
Numbers of shares issued | 12,731,441 | 12,783,087 | 12,825,883 |
| Number of treasury shares | - | - | 100,000 |
Number of shares outstanding at December 31 | 12,731,441 | 12,783,087 | 12,725,883 |
Average number of shares outstanding | 12,716,274 | 12,770,050 | 12,766,549 |
Share price at December 31 (CHF) | 412.40 | 383.40 | 202.60 |
High (CHF) | 515.00 | 428.00 | 373.80 |
Low (CHF) | 268.20 | 256.40 | 197.50 |
Average number of traded shares per day1 | 30,874 | 32,253 | 35,742 |
Average trading volume per day (CHF)1 | 14,925,418 | 11,310,160 | 10,687,930 |
INFORMATION PER SHARE
| 2022 | 2023 | 2024 |
Basic earnings per share (CHF/share) | 9.53 | 10.34 | 5.3 |
Adjusted earnings per share (CHF/share) | 12.14 | 12.88 | 8.08 |
Shareholders’ equity at December 31 (CHF 1,000) | 1,357,720 | 1,348,910 | 1,453,331 |
Dividend (CHF) | 2.90 | 3.002 | 3.002 |
Dividend yield (%)3 | 0.70% | 0.87% | 1.48% |
FINANCIAL RATIOS
| 2022 | 2023 | 2024 |
Market capitalization (CHF million)4 | 5,250.4 | 4,389.7 | 2,578.3 |
Price Earnings Ratio5 | 33.97 | 26.66 | 25.07 |
- 1 Including off-exchange trading
2 Proposal to the Annual General Meeting of Shareholders on April 10, 2025
3 At share price as of Dec 31
4 Number of shares outstanding at Dec 31 multiplied with share price as of Dec 31
5 Share price as of Dec 31 divided by adjusted earnings per share